PACERONE Drug Patent Profile
✉ Email this page to a colleague
When do Pacerone patents expire, and what generic alternatives are available?
Pacerone is a drug marketed by Upsher Smith Labs and is included in one NDA.
The generic ingredient in PACERONE is amiodarone hydrochloride. There are fifteen drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the amiodarone hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Pacerone
A generic version of PACERONE was approved as amiodarone hydrochloride by TEVA PHARMS on November 30th, 1998.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PACERONE?
- What are the global sales for PACERONE?
- What is Average Wholesale Price for PACERONE?
Summary for PACERONE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 111 |
| Clinical Trials: | 10 |
| Patent Applications: | 793 |
| Drug Prices: | Drug price information for PACERONE |
| Drug Sales Revenues: | Drug sales revenues for PACERONE |
| DailyMed Link: | PACERONE at DailyMed |
US Patents and Regulatory Information for PACERONE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Upsher Smith Labs | PACERONE | amiodarone hydrochloride | TABLET;ORAL | 075135-002 | Apr 12, 2005 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Upsher Smith Labs | PACERONE | amiodarone hydrochloride | TABLET;ORAL | 075135-001 | Apr 30, 1998 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Upsher Smith Labs | PACERONE | amiodarone hydrochloride | TABLET;ORAL | 075135-003 | Jul 2, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
